Alexion Pharmaceuticals (ALXN) PT Lowered to $190 at Citi
Tweet
Share
E-mail
Get Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Citi analyst Robyn Karnauskas lowered the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $190.00 (from $195.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts TJX Companies rating to Neutral, lowers price target
- Mirvac Group (MGR:AU) (MRVGF) PT Lowered to AUD2.25 at JPMorgan
- Hesai (2525:HK) (HSAI) PT Lowered to HK$24.20 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
